Together, these data supported the hypothesis that DUSP9 exerts a tumor suppressive role in HCC by inactivating the ERK pathway and lowering the level of the ERK targets MYC and Cyclin D1 [15]. The gene discussed is DUSP9; the disease is neoplasm.